Spitalul Clinic De Urgenta Pentru Copii Sfanta Maria Iasi

The medical center is at the forefront of pediatric dermatology, focusing on innovative treatments for moderate to severe plaque psoriasis in children. Through extensive research, the center evaluates the pharmacokinetics, efficacy, and safety of novel therapies, such as deucravacitinib, to improve patient outcomes.

• Pharmacokinetics in Pediatric Populations
• Innovative Psoriasis Treatments
• Safety and Tolerability in Long-term Use

By advancing the understanding of how these treatments work in younger patients, the center contributes significantly to the development of safer and more effective therapeutic options for pediatric dermatological conditions.

Specializing in pediatric neurology, the center conducts pivotal studies on the efficacy and safety of treatments for childhood absence epilepsy and juvenile absence epilepsy. The research focuses on the use of brivaracetam, aiming to provide effective monotherapy options for young patients.

• Monotherapy Efficacy in Epilepsy
• Long-term Safety of Antiepileptic Drugs
• Innovative Approaches to Epilepsy Management

Through these studies, the center enhances the understanding of epilepsy management in children and young adults, paving the way for improved therapeutic strategies and better quality of life for patients.

The center is a leader in the field of pediatric headache and migraine research, focusing on the safety and efficacy of treatments like lasmiditan for children aged 6 to 17. This research aims to provide effective relief for young migraine sufferers, improving their daily functioning and overall well-being.

• Safety and Efficacy of Migraine Treatments
• Innovative Therapeutic Approaches
• Improving Quality of Life for Pediatric Patients

By exploring new treatment avenues, the center contributes to the development of targeted therapies that address the unique needs of pediatric migraine patients, offering hope for better management of this debilitating condition.